/
CDT
$2.86-$0.28 (-9.06%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$1.9M
1M shares
52-week range
$2.53 – $3,600.00
0% from low
Sector
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
CS
Change$-31139997.14
CDT Equity Inc. Common Stock
CDT Equity Inc is a data-driven biopharmaceutical development company focused on identifying, enhancing, and advancing high-potential therapeutic assets through scientific innovation and strategic partnerships. It has evolved into a broader, more agile platform that leverages artificial intelligence, solid-form chemistry, and efficient asset repositioning to accelerate the development of novel treatments. The company's pipeline includes candidates that target autoimmune disorders, as well as idiopathic male infertility, oncology, dermatology, rare disease and animal health. It has one operating segment focused on the research and development of clinical assets.
www.cdtequity.com- Employees
- 4
- IPO / List date
- Sep 25, 2023
- HQ
- NAPLES, FL
Held by traders on TradeandTell
No one on the platform currently holds CDT.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in CDT as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2026-07-20 | 1-for-10reverse |
| 2026-03-27 | 1-for-25reverse |
| 2025-10-13 | 1-for-8reverse |
| 2025-05-20 | 1-for-15reverse |
| 2025-01-27 | 1-for-100reverse |
Recent trades on TradeandTell
No one on the platform has traded CDT yet.
